Association between tumor necrosis factor-α-308G/A polymorphism and obstructive sleep apnea: A meta-analysis

Genetic Testing and Molecular Biomarkers

Volumn 16, Issue 4, 2012, Pages 246-251

  Huang, Jian ^a   Liao, Ning ^a   Huang, Qiu Pin ^a   Xie, Zheng Fu ^a  

^a GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ALLELE; ARTICLE; CASE CONTROL STUDY; CONFIDENCE INTERVAL; DISEASE ASSOCIATION; GENETIC POLYMORPHISM; HUMAN; RISK ASSESSMENT; SLEEP APNEA SYNDROME; SYSTEMATIC REVIEW;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHILD; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; POLYMORPHISM, GENETIC; SLEEP APNEA, OBSTRUCTIVE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84860200109     PISSN: 19450265     EISSN: 19450257     Source Type: Journal    
DOI: 10.1089/gtmb.2011.0170     Document Type: Article

References (16)

1. Bhushan B, Guleria R, Misra A, et al. (2009) TNF-alpha gene polymorphism and TNF-alpha levels in obese Asian Indians with obstructive sleep apnea. Respir Med 103:386-392.
2. Campana L, Eckert DJ, Patel SR, et al. (2010) Pathophysiology & genetics of obstructive sleep apnoea. Indian J Med Res 131:176-187.
3. Ciftci TU, Kokturk O, Bukan N, et al. (2004) The relationship between serum cytokine levels with obesity and obstructive sleep apnea syndrome. Cytokine 28:87-91.
4. Elahi MM, Asotra K, Matata BM, et al. (2009) Tumor necrosis factor alpha - 308 gene locus promoter polymorphism: an analysis of association with health and disease. Biochim Biophys Acta 1792:163-172.
5. Kent BD, Ryan S, McNicholas WT. (2010) The genetics of obstructive sleep apnoea. Curr Opin Pulm Med 16:536-542.
6. Khalyfa A, Serpero LD, Kheirandish-Gozal L, et al. (2011) TNF-α gene polymorphisms and excessive daytime sleepiness in pediatric obstructive sleep apnea. J Pediatr 158:77-82.
7. Krueger JM (2008) The role of cytokines in sleep regulation. Curr Pharm Des 14:3408-3416.
8. Li NF, Yao XG, Zhu J, et al. (2010) Higher levels of plasma TNFalpha and neuropeptide Y in hypertensive patients with obstructive sleep apnea syndrome. Clin Exp Hypertens 32:54-60.
9. Liu HG, Guan P, Lin M, et al. (2006) The relationship between tumor necrosis factor-alpha gene promoter polymorphism and obstructive sleep apnea-hypopnea syndrome. Zhonghua Jie He He Hu Xi Za Zhi 29:596-599.
10. Chinese. Popko K, Gorska E, Potapinska O, et al. (2008) Frequency of distribution of inflammatory cytokines IL-1, IL-6 and TNFalpha gene polymorphism in patients with obstructive sleep apnea. J Physiol Pharmacol 59:607-614.
11. Popko K, Gorska E, Stoklosa A, et al. (2009) The relation between IL-6 (G174C) and TNF-alpha (G308A) genes polymorphisms and IL-6 or TNF-alpha level in osas (obstructive sleep apnea syndrome) and control patients. Eur J Immunol 39 Suppl 1: S216.
12. Riha RL, Brander P, Vennelle M, et al. (2005) Tumour necrosis factor-alpha (-308) gene polymorphism in obstructive sleep apnoea-hypopnoea syndrome. Eur Respir J 26:673-678.
13. Riha RL, Gislasson T, Diefenbach K (2009) The phenotype and genotype of adult obstructive sleep apnoea/hypopnoea syndrome. Eur Respir J 33:646-655.
14. Wilson AG, Symons JA, McDowell TL, et al. (1997) Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci U S A 94:3195-3199.
15. Young T, Peppard PE, Gottlieb DJ (2002) Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med 165:1217-1239.
16. Zamarron C, García Paz V, Riveiro A (2008) Obstructive sleep apnea syndrome is a systemic disease. Current evidence. Eur J Intern Med 19:390-398.